Picture of Anteotech logo

ADO — Anteotech Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m-10.55%
3m-48.21%
6m-47.53%
1yr-69.48%
Volume Change (%)
10d/3m-59.99%
Price vs... (%)
52w High-75.9%
50d MA-7.61%
200d MA-48.07%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value10.72
Price to Tang. Book10.72
Price to Free Cashflown/a
Price to Sales273.81
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-54.24%
Return on Equity-69.71%
Operating Margin-1491.72%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Anteotech EPS forecast chart

Profile Summary

AnteoTech Limited is an Australia-based surface chemistry company. The principal activities of the Company consist of research, development, and commercialization of nanotechnologies with surface management applications. The activities are primarily focused on the commercialization of these technologies across applications in the life science and energy markets. Its technology products include AnteoCoat, AnteoBind, and AnteoRelease. AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a rapid, single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. It also offers bioconjugation and assay development services to assist POC and diagnostics researchers and manufacturers. AnteoCoat is a suite of compounds that enable the control of material interactions and properties in entirely new ways. It also offers ready-to-use kits.

Directors

Last Annual
June 30th, 2021
Last Interim
December 31st, 2021
Incorporated
June 26th, 1995
Public Since
April 11th, 2000
No. of Employees
24
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
1,974,044,392

ADO Share Price Performance

Upcoming Events for ADO

Full Year 2022 Anteotech Ltd Earnings Release

Similar to ADO

Picture of Actinogen Medical logo

Actinogen Medical

au flag iconAustralian Stock Exchange - SEATS

Picture of Adalta logo

Adalta

au flag iconAustralian Stock Exchange - SEATS

Picture of Alterity Therapeutics logo

Alterity Therapeutics

au flag iconAustralian Stock Exchange - SEATS

Picture of Amplia Therapeutics logo

Amplia Therapeutics

au flag iconAustralian Stock Exchange - SEATS

Picture of Anatara Lifesciences logo

Anatara Lifesciences

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email